Top Markets
Coin of the day
Anew Medical, Inc. Anew Medical, Inc.

Anew Medical, Inc.

WENA
Rank in Stocks #33455
Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing... Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing innovative treatments for conditions affecting the brain and nervous system, age-related illnesses, and specialized diagnostic tools. Their pipeline includes advanced cell and gene therapies specifically designed to alleviate symptoms of aging-related conditions, such as dementia, Alzheimer's disease, and various neuromuscular disorders. Additionally, Anew Medical is engaged in developing biologics and biosimilars for cancer treatment, alongside research into therapies targeting melanocortin receptors. A key strategic alliance exists with Japan's Okinawa Research Center, focusing on the collaborative research and development of Klotho gene therapy. This initiative aims to extend human longevity and diminish the impact of age-related diseases. The company maintains its headquarters in Omaha, Nebraska.
Share Price
$0.5099
Last synced: 2024-10-15
Market Cap
$7.60M
Change (1 day)
2.02%
Change (1 year)
0.00%
Country
US
Trade Anew Medical, Inc. (WENA)

Category

EPS for Anew Medical, Inc. (WENA)
EPS as of June 2024 TTM: $0.00
According to Anew Medical, Inc. latest financial reports and stock price the company's current EPS (TTM) is $0.00. At the end of 2022 the company had a EPS of $0.08 an increase over its 2021 EPS that were of $-0.09.
EPS history for Anew Medical, Inc. from 2021 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) 0.00 -102.64%
2023 $0.14 69.29%
2022 $0.08 -196.73%
2021 $-0.09 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
$17.32 -468,208.11%
US
$27.74 -749,829.73%
NL
- -
CH
- -
KR
$13.70 -370,372.97%
BE